-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DjifhLhvul6CCyy+kbrJrArilQdJmH0CdLOzzhOSEty7fmx+5UsjAgM2fEq3tjud i/JVH78XqtBOUjTG+gfPgQ== 0001096906-08-001002.txt : 20080516 0001096906-08-001002.hdr.sgml : 20080516 20080516172735 ACCESSION NUMBER: 0001096906-08-001002 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080516 DATE AS OF CHANGE: 20080516 EFFECTIVENESS DATE: 20080516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PARADIGM MEDICAL INDUSTRIES INC CENTRAL INDEX KEY: 0000916444 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870459536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-28498 FILM NUMBER: 08843369 BUSINESS ADDRESS: STREET 1: 2355 SOUTH 1070 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84119 BUSINESS PHONE: 8019778970 MAIL ADDRESS: STREET 1: 2355 SOUTH 1070 WEST CITY: SALT LAKE CITY STATE: UT ZIP: 84119 NT 10-Q 1 paradigmnt10q033107.txt PARADIGM MEDICAL INDUSTRIES, INC. ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-28498 (Check one) |_| Form 10-K and Form 10-KSB |_| Form 11-K |_| Form 20-F |X| Form 10-Q and Form 10-QSB |_| Form N-SAR For period ended: March 31, 2008 |_| Transition Report on Form 10-K and Form 10-KSB |_| Transition Report on Form 20-F |_| Transition Report on Form 11-K |_| Transition Report on Form 10-Q and Form 10-QSB |_| Transition Report on Form N-SAR For the transition period ended _____________________________________________ Read Attached Instruction Sheet Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates_________________________ _______________________________________________________________________________ PART I REGISTRANT INFORMATION Full name of registrant: Paradigm Medical Industries, Inc. Former name if applicable: ____________________________________________________ Address of principal executive office (Street and number): 2355 South 1070 West Salt Lake City, Utah 84119 PART II RULE 12b-25(b) AND (c) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 132b-25(b), the following should be completed. (Check box if appropriate). (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense. |X| (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and (c) The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable. PART III NARRATIVE State below in reasonable detail the reasons why Forms 10-K, 11-K, 10-Q, N-SAR or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.) The Form 10-QSB cannot be completed within the prescribed time period due to the additional time required because of complexities involved in completing the required financial statements, especially in complying with the disclosure requirements of Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, which was issued by The Financial Accounting Standard Board. PART IV OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Randall A. Mackey (801) 575-5000 ----------------- ----------- ------------------ (name) (area code) (telephone number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). |X| Yes |_| No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. |_| Yes |X| No Paradigm Medical Industries, Inc. ---------------------------------- (Name of Registrant as Specified in Charter) Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 16, 2008 By: /s/ Raymond P.L. Cannefax ------------------------------------- Raymond P.L. Cannefax President and Chief Executive Officer - -------------------------------------------------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----